Obstructive Airways DiseaseNew GINA Guidelines: Controversy Still ExistsEl-Qutob, David PhD, MD*; Maillo, Martin MD†Author Information *Unit of Allergy, Universitary Hospital of La Plana, Vila-Real, Spain †Buen Aire Institute, Santa Fe, Argentina Disclosure: The authors declare that they have no conflicts of interest. Address correspondence to: David El-Qutob, PhD, MD, Unit of Allergy, Universitary Hospital of La Plana, Carretera Vila-Real-Burriana Km. 0.5, Vila-Real (Castellon) 12540, Spain. E-mail: firstname.lastname@example.org. Clinical Pulmonary Medicine: May 2020 - Volume 27 - Issue 3 - p 61-63 doi: 10.1097/CPM.0000000000000356 Buy Metrics Abstract Bronchial asthma is an extended chronic inflammatory respiratory disease that represents a serious health problem. Management of asthmatic patients should be ensured by the use of asthma guidelines such as Global Initiative for Asthma (GINA). The last changes made in the GINA guide have generated controversy. This article reviews the reasons for the changes in the guide and the problems that could emerge in the management of the asthmatic patient. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.